Publications by authors named "A B Zain"
This study analyzed 1432 questions asked in 19 surveys ( = 43,014) on COVID-19 vaccines between January 2020 and August 2022 using dimensions including (1) information sources about COVID-19 vaccine, (2) information about the access, effectiveness, and side effects of COVID-19 vaccine, (3) COVID-19 vaccine hesitancy (i.e. false perception, skepticism, and vaccine refusal), (4) motivations to get the COVID-19 vaccine (i.
View Article and Find Full Text PDFBackground: Nonalcoholic fatty liver disease (NAFLD) is increasingly concerning due to its rising prevalence. It encompasses conditions from simple steatosis to severe nonalcoholic steatohepatitis (NASH), posing risks such as fibrosis, cirrhosis, or hepatocellular carcinoma if untreated. This systematic review and meta-analysis aims to assess aldafermin, an FGF19 analog, for efficacy and safety in NASH patients.
View Article and Find Full Text PDFArticle Synopsis
- Myasthenia gravis (MG) is a disease that makes muscles weak and can lead to a serious problem called myasthenic crisis, which affects breathing.
- Two treatments for this crisis are intravenous immunoglobulins (IVIg) and plasmapheresis (PLEX), but it's hard to determine which one works better.
- The choice of treatment depends on the patient's situation, available resources, and doctor's opinion, and more research is needed to create clear guidelines for helping patients.
Aim: This case series was to describe the use of surgical extrusion for three different cases as a technique to re-establish the biological width in patients with insufficient crown height.
Background: Surgical extrusion serves as an important means to reestablishing a proper biological width. Such method provides an excellent alternative for the restoration of teeth with insufficient ferrule and ensuring a suitable dental restoration.
Article Synopsis
- - Sickle cell disease (SCD) is a hereditary blood disorder that leads to chronic pain, anemia, and various health complications, but advancements in treatments have improved patient outcomes over time.
- - Despite progress, challenges like limited access to stem cell transplants and complications from current therapies highlight the need for ongoing research in SCD treatments.
- - The recent FDA approval of Casgevy, a CRISPR/Cas9-based gene therapy, represents a significant step in SCD treatment, with the review focusing on its potential effectiveness and safety compared to traditional methods, emphasizing the need for long-term research.